The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis
Abstract Background Residual disease following cytoreductive surgery in patients with ovarian cancer has been associated with poorer survival outcomes compared with no residual disease. We performed a meta-analysis to assess the impact of varying levels of residual disease status on survival outcome...
Saved in:
Main Authors: | Dana M. Chase (Author), Anadi Mahajan (Author), David Alexander Scott (Author), Neil Hawkins (Author), Linda Kalilani (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Survival impact of bowel resection at the time of interval cytoreductive surgery for advanced ovarian cancer
by: Blair McNamara, et al.
Published: (2021) -
Primary cytoreductive surgery or interval cytoreductive surgery
by: Yiu-Tai Li, et al.
Published: (2024) -
Primary cytoreductive surgery followed by chemotherapy compared to neoadjuvant chemotherapy followed by cytoreduction as a treatment for stage III and IV ovarian cancer (literature review)
by: E. V. Sibirskaya, et al.
Published: (2024) -
Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
by: Soo Young Jeong, et al.
Published: (2019) -
Cholecystectomy at the time of open cytoreductive surgery for ovarian cancer
by: Lindsey Finch, et al.
Published: (2024)